Tejara Capital’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-73,739
| Closed | -$404K | – | 88 |
|
2023
Q4 | $404K | Sell |
73,739
-30,000
| -29% | -$164K | 0.17% | 58 |
|
2023
Q3 | $392K | Sell |
103,739
-29,782
| -22% | -$113K | 0.22% | 54 |
|
2023
Q2 | $895K | Sell |
133,521
-74,034
| -36% | -$496K | 0.44% | 47 |
|
2023
Q1 | $1.35M | Buy |
207,555
+172,800
| +497% | +$1.12M | 0.69% | 38 |
|
2022
Q4 | $296K | Buy |
+34,755
| New | +$296K | 0.17% | 78 |
|